Header Logo

Connection

Rami Doukky to Humans

This is a "connection" page, showing publications Rami Doukky has written about Humans.
Connection Strength

2.000
  1. Is dyspnea the new angina? The ever-changing profile of patients referred for CAD evaluation. J Nucl Cardiol. 2023 08; 30(4):1321-1323.
    View in: PubMed
    Score: 0.066
  2. Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation. J Nucl Cardiol. 2023 10; 30(5):1897-1903.
    View in: PubMed
    Score: 0.065
  3. Coronary artery calcium or epicardial fat: Different markers for different people. J Nucl Cardiol. 2022 08; 29(4):1593-1595.
    View in: PubMed
    Score: 0.056
  4. Cardiac imaging for the assessment of patients being evaluated for liver transplantation. J Nucl Cardiol. 2022 06; 29(3):1078-1090.
    View in: PubMed
    Score: 0.056
  5. Cardiac imaging for the assessment of patients being evaluated for kidney transplantation. J Nucl Cardiol. 2022 04; 29(2):543-557.
    View in: PubMed
    Score: 0.056
  6. The Prognostic Value of MPI in CKD: Can we do better? J Nucl Cardiol. 2022 Feb; 29(1):155-157.
    View in: PubMed
    Score: 0.056
  7. The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging. J Nucl Cardiol. 2022 04; 29(2):826-835.
    View in: PubMed
    Score: 0.054
  8. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging. J Nucl Cardiol. 2022 04; 29(2):810-821.
    View in: PubMed
    Score: 0.054
  9. Ischemia and Viability Testing in New-Onset Heart Failure. Curr Cardiol Rep. 2020 07 06; 22(8):76.
    View in: PubMed
    Score: 0.053
  10. The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date. J Nucl Cardiol. 2022 Feb; 29(1):101-110.
    View in: PubMed
    Score: 0.053
  11. BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Condition. Methodist Debakey Cardiovasc J. 2020 Jul-Sep; 16(3):241-244.
    View in: PubMed
    Score: 0.053
  12. Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy. J Am Coll Cardiol. 2020 04 14; 75(14):1714-1717.
    View in: PubMed
    Score: 0.053
  13. PAMA implementation: The road ahead. J Nucl Cardiol. 2019 12; 26(6):1789-1791.
    View in: PubMed
    Score: 0.051
  14. Challenges in prediction of right ventricular failure among recipients of a left ventricular assist device. J Nucl Cardiol. 2021 02; 28(1):309-310.
    View in: PubMed
    Score: 0.051
  15. Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Am J Cardiovasc Drugs. 2019 Oct; 19(5):465-476.
    View in: PubMed
    Score: 0.051
  16. Straining for New Prognostic Predictors?in Asymptomatic Severe Aortic Regurgitation. JACC Cardiovasc Imaging. 2020 01; 13(1 Pt 1):22-24.
    View in: PubMed
    Score: 0.049
  17. Use of ultrasound enhancing agents in transesophageal echocardiography to improve interpretive confidence of left atrial appendage thrombus. Echocardiography. 2019 02; 36(2):362-369.
    View in: PubMed
    Score: 0.048
  18. Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review. J Nucl Cardiol. 2018 02; 25(1):137-149.
    View in: PubMed
    Score: 0.043
  19. Fully automated analysis of perfusion data: The rise of the machines. J Nucl Cardiol. 2018 08; 25(4):1361-1363.
    View in: PubMed
    Score: 0.043
  20. Promoting Appropriate Use of Cardiac Imaging: No Longer an Academic Exercise. Ann Intern Med. 2017 Mar 21; 166(6):438-440.
    View in: PubMed
    Score: 0.042
  21. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2018 08; 25(4):1313-1323.
    View in: PubMed
    Score: 0.042
  22. Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 10; 24(5):1666-1671.
    View in: PubMed
    Score: 0.040
  23. Derivation and validation of E/e' ratio as a parameter in the evaluation of left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Int J Cardiovasc Imaging. 2016 Sep; 32(9):1349-1356.
    View in: PubMed
    Score: 0.040
  24. Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging. J Nucl Cardiol. 2017 10; 24(5):1571-1578.
    View in: PubMed
    Score: 0.040
  25. Impact of Dietary Sodium Restriction on Heart Failure Outcomes. JACC Heart Fail. 2016 Jan; 4(1):24-35.
    View in: PubMed
    Score: 0.039
  26. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 02; 24(1):112-118.
    View in: PubMed
    Score: 0.039
  27. Impact of insurance carrier, prior authorization, and socioeconomic status on appropriate use of SPECT myocardial perfusion imaging in private community-based office practice. Clin Cardiol. 2015 May; 38(5):267-73.
    View in: PubMed
    Score: 0.037
  28. Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging. J Nucl Cardiol. 2015 Aug; 22(4):700-13.
    View in: PubMed
    Score: 0.037
  29. The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT. J Nucl Cardiol. 2015 Jun; 22(3):526-34.
    View in: PubMed
    Score: 0.037
  30. The prognostic value of undetectable highly sensitive cardiac troponin I in patients with acute pulmonary embolism. Chest. 2015 Mar; 147(3):685-694.
    View in: PubMed
    Score: 0.037
  31. Effective risk stratification of patients on the basis of myocardial perfusion SPECT is dependent on appropriate patient selection. Curr Cardiol Rep. 2015 Jan; 17(1):549.
    View in: PubMed
    Score: 0.036
  32. Rheumatic heart disease in modern urban America: a cohort study of immigrant and indigenous patients in Chicago. Int J Cardiol. 2014 Jul 15; 175(1):178-80.
    View in: PubMed
    Score: 0.035
  33. The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Cardiovasc Ultrasound. 2014 Feb 25; 12:10.
    View in: PubMed
    Score: 0.034
  34. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.
    View in: PubMed
    Score: 0.034
  35. Reply: To PMID 23496263. Echocardiography. 2013 Oct; 30(9):1122.
    View in: PubMed
    Score: 0.033
  36. The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease. J Nucl Cardiol. 2013 Oct; 20(5):774-84.
    View in: PubMed
    Score: 0.033
  37. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography. 2013 Sep; 30(8):889-95.
    View in: PubMed
    Score: 0.032
  38. The prognostic value of cardiac SPECT performed at the primary care physician's office. J Nucl Cardiol. 2013 Aug; 20(4):519-28.
    View in: PubMed
    Score: 0.032
  39. Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
    View in: PubMed
    Score: 0.030
  40. Ambulatory cardiac single-photon emission computed tomography at the primary care physician's office: a descriptive study. J Ambul Care Manage. 2010 Oct-Dec; 33(4):328-35.
    View in: PubMed
    Score: 0.027
  41. Feasibility and safety of laser balloon pulmonary vein isolation in patients with prior left atrial appendage occlusion device implantation. J Cardiovasc Electrophysiol. 2022 11; 33(11):2389-2393.
    View in: PubMed
    Score: 0.016
  42. Part II: risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review. J Invasive Cardiol. 2002 May; 14(5):254-62.
    View in: PubMed
    Score: 0.015
  43. Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2022 06; 99(7):2101-2110.
    View in: PubMed
    Score: 0.015
  44. Risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review. J Invasive Cardiol. 2002 Apr; 14(4):215-20.
    View in: PubMed
    Score: 0.015
  45. Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis. Eur Heart J. 2021 08 31; 42(33):3190-3199.
    View in: PubMed
    Score: 0.014
  46. Sex Differences in COVID-19 Hospitalization and Mortality. J Womens Health (Larchmt). 2021 05; 30(5):646-653.
    View in: PubMed
    Score: 0.014
  47. Discontinuation and non-publication of heart failure randomized controlled trials: a call to publish all trial results. ESC Heart Fail. 2021 02; 8(1):16-25.
    View in: PubMed
    Score: 0.014
  48. Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. Am Heart J. 2020 12; 230:71-81.
    View in: PubMed
    Score: 0.014
  49. Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 08; 96(2):413-421.
    View in: PubMed
    Score: 0.013
  50. Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry. Heart Rhythm. 2020 01; 17(1):81-89.
    View in: PubMed
    Score: 0.013
  51. Level and Prevalence of Spin in Published Cardiovascular Randomized Clinical Trial Reports With Statistically Nonsignificant Primary Outcomes: A Systematic Review. JAMA Netw Open. 2019 05 03; 2(5):e192622.
    View in: PubMed
    Score: 0.012
  52. Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2019 09 15; 291:134-139.
    View in: PubMed
    Score: 0.012
  53. Impact of Hospice and Palliative Care Service Utilization on All-Cause 30-Day Readmission Rate for Older Adults Hospitalized with Heart Failure. Am J Hosp Palliat Care. 2019 Jul; 36(7):623-629.
    View in: PubMed
    Score: 0.012
  54. Coming-of-age: The ImageGuide? Registry at three. J Nucl Cardiol. 2019 02; 26(1):72-75.
    View in: PubMed
    Score: 0.012
  55. ASNC imaging guidelines for nuclear cardiology procedures : Standardized reporting of nuclear cardiology procedures. J Nucl Cardiol. 2017 12; 24(6):2064-2128.
    View in: PubMed
    Score: 0.011
  56. The Impact of Hospital and Surgeon Volume on In-Hospital Mortality of Ventricular Assist Device Recipients. J Card Fail. 2016 Mar; 22(3):226-31.
    View in: PubMed
    Score: 0.010
  57. Congestive heart failure adherence redesign trial: a pilot study. BMJ Open. 2014 Dec 04; 4(12):e006542.
    View in: PubMed
    Score: 0.009
  58. Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes. Diabetes Res Clin Pract. 2010 May; 88(2):189-95.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.